Market Cap (In KRW)
904.44 Billion
Revenue (In KRW)
689.07 Million
Net Income (In KRW)
-32.92 Billion
Avg. Volume
218.95 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7610.0-20900.0
- PE
- -
- EPS
- -
- Beta Value
- 1.083
- ISIN
- KR8702070002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. So-Yeon Park
- Employee Count
- -
- Website
- https://www.prestigebiopharma.com
- Ipo Date
- 2021-02-09
- Details
- Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also developing vaccines for COVID-19 virus. The company was incorporated in 2015 and is headquartered in Singapore.
More Stocks
-
WYGPFWorley Limited
WYGPF
-
TEMPF
-
LUDN
-
008730Youlchon Chemical Co.,Ltd.
008730
-
BDCBelden Inc.
BDC
-
LIFFFLi-FT Power Ltd.
LIFFF
-
300420
-
DNNGYØrsted A/S
DNNGY